metoclopramide 5 mg
1 INDICATIONS AND USAGE Metoclopramide tablets are indicated for the: Treatment for 4 to 12 weeks of symptomatic, documented gastroesophageal reflux in adults who fail to respond to conventional therapy. ( 1 ) Relief of symptoms in adults with acute and recurrent diabetic gastroparesis. ( 1 ) Limitations of Use: Metoclopramide tablets are not recommended for use in pediatric patients due to the risk of tardive dyskinesia (TD) and other extrapyramidal symptoms as well as the risk of methemoglobinemia in neonates. ( 1 , 8.4 ) Metoclopramide tablets are indicated for the: Treatment for 4 to 12 weeks of symptomatic, documented gastroesophageal reflux in adults who fail to respond to conventional therapy. Relief of symptoms in adults with acute and recurrent diabetic gastroparesis. Limitations of Use : Metoclopramide tablets are not recommended for use in pediatric patients due to the risk of developing tardive dyskinesia (TD) and other extrapyramidal symptoms as well as the risk of methemoglobinemia in neonates [see Use in Specific Populations ( 8.4 )].
ipca laboratories limited
OVAL WHITE RF10
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING Each white to off white, capsule shaped, biconvex
METOCLOPRAMIDE tablet, USP contains 10 mg of
METOCLOPRAMIDE base as
METOCLOPRAMIDE hydrochloride, USP. The tablets have "RF11" embossed on one side and score line on the other side. Available in: Bottle of 100 tablets NDC 83980-011-01 Bottle of 500 tablets NDC 83980-011-05 Bottle of 1,000 tablets NDC 83980-011-10 Each white to off white, oval shaped, biconvex
METOCLOPRAMIDE tablet, USP contains 5 mg of
METOCLOPRAMIDE base as
METOCLOPRAMIDE hydrochloride, USP. The tablets have "RF10" embossed on one side and plain on the other side. Available in: Bottle of 100 tablets NDC 83980-010-01 Bottle of 500 tablets NDC 83980-010-05 Dispense tablets in tight, light-resistant container. Store between 20°C to 25°C (68°F to 77°F) [See USP Controlled Room Temperature].
More pills like OVAL RF10